BI 3810477

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Healthy

Phase 1

A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy Men

CompletedNCT06631430

Boehringer IngelheimHealthy

Start: 2024-10-30End: 2025-06-12Updated: 2025-06-18

A Study to Test How Well Multiple Doses of BI 3810477 Are Tolerated by Healthy Adults

CompletedNCT06984926

Boehringer IngelheimHealthy

Start: 2025-06-06End: 2026-03-09Updated: 2026-03-19